Yahoo! Finance Search - Finance Home - Yahoo! - Help

Wednesday, May 4 2016 5:41pm ET - U.S. Markets Closed.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Delivery News
Latest News
Wednesday, May 4, 2016
·Delcath Announces First Quarter Financial Results
PR Newswire - 1 hour, 41 minutes ago
·Bio-Path Holdings to Announce First Quarter 2016 Financial Results on May 11, 2016
GlobeNewswire - 1 hour, 41 minutes ago
·FDA Warns of Rare Reactions to Abilify Medication
at The Wall Street Journal Online - Tue 10:38 pm ET
Tuesday, May 3, 2016
·Valeant Shares Spike as New CEO Joseph Papa Takes Office
at - Tue 1:55 pm ET
·Credit-Rating Companies Ease Up on Valeant (Slightly)
at The Wall Street Journal Online - Tue 1:34 pm ET
·Valeant (VRX) Stock Soars as Papa Assumes CEO Role
at - Tue 1:18 pm ET
·Credit Rating Agencies More Favorable Toward Valeant
at - Tue 12:45 pm ET
·VRX Escrow Corp. -- Moody's confirms Valeant's B2 CFR; upgrades PDR to B2-PD; outlook negative
- Tue 11:46 am ET
·Valeant Pharmaceuticals: What, Me Worry?
at - Tue 10:17 am ET
·Moody's: Moody's Liquidity Stress Index marginally decreases
- Tue 9:25 am ET
·Leading U.S. Cancer Centers Join Delcath's Focus Phase 3 Trial For Patients With Hepatic Dominant Ocular Melanoma
PR Newswire - Tue 8:00 am ET
·Joseph C. Papa Assumes Role Of Chairman And Chief Executive Officer Of Valeant Pharmaceuticals
PR Newswire - Tue 7:00 am ET
·Joseph C. Papa Assumes Role Of Chairman And Chief Executive Officer Of Valeant Pharmaceuticals
CNW Group - Tue 7:00 am ET
Monday, May 2, 2016
·Tweets on the Street: Puerto Rico Defaults, Ackman Speaks, Starbucks Iced Out
at - Mon 4:53 pm ET
·Why Bill Ackman Regrets Buying Valeant
at Fortune - Mon 4:28 pm ET
·Acura Pharmaceuticals Announces First Quarter 2016 Financial Results
Marketwire - Mon 4:15 pm ET
·Flamel Technologies to Report First Quarter 2016 Results
Marketwire - Mon 4:05 pm ET
·One Reason Why Valeant (VRX) Stock Is Plummeting Today
at - Mon 12:23 pm ET
·Valeant Pharmaceuticals: The 10-K is Filed But…
at - Mon 10:49 am ET
·Valeant’s departing CEO Michael Pearson was key force on pricing
at MarketWatch - Mon May 2
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds

Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?